Traditional Phase 1, 2, and 3 oncology trials are becoming increasingly difficult and time-consuming due to the number of different genetic mutations and cancer types that continue to be discovered.
Basket trials have emerged as an innovative new trial design that can significantly speed the drug development process, but adoption of this new study design can be complicated. High startup costs, complex protocols, contract complications and regulatory approval are some of the biggest obstacles that can prevent trial completion and ultimately delay an effective medicine reaching a patient.
Register for this webinar to discover:
May 23, 2018